期刊文献+

转化医学平台下提升高等药学院校新药研发水平的思考 被引量:2

The Thinking of Promoting the Level of Pharmaceutical Universities New Drug Research and Development in Translational Medicine Platform
原文传递
导出
摘要 高等药学院校作为我国新药研发的主力军,担负着研发出具有我国自主知识产权新药的重任.转化医学概念的提出为提高新药研发效率提供了机遇和挑战.目前国内高等药学院校陆续成立的转化医学中心,为促进新药研发提供了切实有益的条件.本文分析了行政管理完善转化医学平台建设,推动新药研发的途径. As the main force of new drug research and development (R&D) in China,pharmaceutical universities are in charge of developing new drugs with our own intellectual property rights.The concept of translational medicine provides opportunity and challenge to improve the efficiency of new drug R&D.Several translational medicine centers have been set up in pharmaceutical universities,which provide practical conditions for new drug R&D in domestic.Administration management approaches to promote new drug R&D in translational medicine platform are analyzed in the paper.
作者 王殉 刘俊义
机构地区 北京大学药学院
出处 《中华医学科研管理杂志》 2014年第1期2-4,共3页 Chinese Journal of Medical Science Research Management
关键词 转化医学 高等药学院校 新药研发 行政管理 Translational medicine Pharmaceutical universities New drug research and development Administration management
  • 相关文献

参考文献6

二级参考文献40

  • 1Geraghty J. Adenomatous polyposis coli and translational medicine[ J ]. Lancet, 1996, 348:433 - 435.
  • 2院士之家工作简报.加快转化研究发展,跨越医学“死亡之谷”[OL].http://www.cae-shc.gov.cn/index-detail.aspx?sortlD=4&subID=11&ID=1198[2009-11-25].
  • 3Mission of NCRR [ OL]. http://www, ncrr. nih. gov/about% 5Fus/mission_statement. asp. [2009 - 11 - 12].
  • 4Clinical Research Resources[OL]. http://www. ncrr. nih.gov/cr. [2009 - 11 - 25].
  • 5Clinical and Translational science Awards [OL]. http://www. ctsaweb, org. [2009 - 11 - 25].
  • 6Comparative Medicine [OL]. http://www, ncrr. nih. gov/cm. [2009 - 11 -22].
  • 7Biomedical Technology[OL]. http://www. ncrr. nih. gov/ bt. [2009-10-21].
  • 8Research Infrastructure [OL]. http ://www. ncrr. nih. gov/ ri. [2009-10-23].
  • 9NCRR Strategic Priorities 2009 - 2013. http ://www. ncrr. nih. gov/strategic_plan/. [ 2009 - 10 - 21 ].
  • 10中国工程院.转化医学发展战略研讨会介绍[OL].http://www.eae.cn/cn/yuandihezuo/shanghaishi/20091106/cael7445.html.[2009-11-27].

共引文献139

同被引文献39

  • 1Choi DW. Bench to bedside: the glutamate connection[J]. Science, 1992, 258(5080): 241-243.
  • 2Geller RB, Karp JE. Adult acute leukemia: a need for continued translational research[ J]. Blood, 1994, 84( 11 ) : 3980-3981.
  • 3Geraghty J. Adenomatous polyposis coll and translational medicine [J]. Lancet, 1996, 348(9025) : 422.
  • 4Hengstler JG,Bolt HM.Failure in drug development:the role of inhibition and induction of cytochrome P450enzymes[J].Arch Toxicol,2008,82(10):665.
  • 5Kola I.The state of innovation in drug development[J].Clin Pharmacol Ther,2008,83(2):227.
  • 6Morgan S,Grootendorst P,Lexchin J,et al.The cost of drug development:a systematic review[J].Health Policy,2011,100(1):174.
  • 7Nyigo VA,Malebo HM.Drug discovery and developments in developing countries:bottlenecks and way forward[J].Tanzan Health Res Bull,2005,7(3):154.
  • 8Swinney DC,Anthony J.How were new medicines discovered?[J].Nat Rev Drug Discov,2011,10(7):507.
  • 9Arrowswith J,Miller P.Trial watch:phaseⅡand phaseⅢattrition rates 2011-2012[J].Nat Rev Drug discov,2013,12(8):569.
  • 10Zerhouni E.Turning the titanic[J].Sci Transl Med,2014,6(221):221.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部